Alveo Technologies Launches Innovative Avian Influenza Testing Solution
The Alveo Sense™ Poultry Avian Influenza Test provides accurate, laboratory-grade testing at the Point of Need™ through a sophisticated cloud-connected platform. This test is primed to change the landscape of poultry health diagnostics.
Research Breakthroughs by the Poultry Research and Diagnostic Center
In a recent study conducted by the Poultry Research and Diagnostic Center (PDRC), significant advancements were made in identifying the H5N1 virus in poultry. This revolutionary test can pinpoint avian influenza during the acute infection phase in chickens and ducks, showcasing its reliability and efficacy in real-world scenarios.
Details on the Testing Process
During the research, two phases were implemented. The first phase included ducks monitored consistently over five days, where samples were taken and analyzed to assess viral load. The second phase evaluated infected birds over a six-day timeline ensuring accuracy in detecting the H5N1 strain.
Accuracy and Sensitivity Results
Results indicated over 99% accuracy in detecting Type A and H5 targets from pooled samples, even at low viral loads, underscoring Alveo's powerful analytical capabilities. These findings reveal how effectively the Alveo Sense test can serve in distinguishing various strains of avian influenza.
Transformation in Disease Management
Shaun Holt, CEO at Alveo, emphasized the importance of their platform for timely intervention in the face of avian flu threats. Alveo's advancements shift the approach to molecular testing from centralized laboratories to deployable solutions on-site, enabling rapid response efforts.
Global Applications and Future Directions
The Alveo Sense is already operational across various international regions including the EU and Southeast Asia, expanding its reach to ensure poultry health on a global scale. By leveraging this technology, industries improve biosecurity measures and streamline infection control processes that previously hindered poultry production.
Addressing Challenges in Poultry Health
Proper assessment of poultry for avian flu is more critical than ever as outbreaks continue to escalate. Dr. Daniel Perez, a distinguished figure at PDRC, highlighted the implications of this molecular testing in bio-surveillance efforts; it paves the way for making informed decisions swiftly.
About Alveo Technologies
Alveo Technologies is on a mission to transform diagnostics into a quick and accessible resource across industries, ensuring the health of poultry and the safety of food supplies. With its portable, multiplex-capable testing platform, Alveo Sense™, the company leads the market in providing insightful data to help manage global health and biosecurity standards.
Frequently Asked Questions
What is the Alveo Sense™ Poultry Avian Influenza Test?
It is a portable molecular test designed to detect H5 and H7 avian influenza virus strains in poultry, delivering rapid results on-site.
How accurate is this test?
The test has shown over 99% accuracy in detecting avian influenza infections, even at low viral loads.
Where is the technology currently in use?
It is being utilized in the EU, Middle East, and Southeast Asia, enhancing poultry health diagnostics globally.
Who conducted the research for the testing validation?
The studies were conducted by the Poultry Research and Diagnostic Center and highlighted during a presentation at a significant international seminar.
What are the broader impacts of this testing technology?
This technology is aimed at improving biosecurity measures and response times to outbreaks, ultimately ensuring better management of poultry health.
